The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Epstein–Barr virus-associated lymphomas
Open accessAbstract
Epstein–Barr virus (EBV), originally discovered through its association with Burkitt lymphoma, is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and malignant lymphomas of B-, T- and NK-cell origin. Some occur as rare accidents of virus persistence in the B lymphoid system, while others arise as a result of viral entry into unnatural target cells. The early finding that EBV is a potent B-cell growth transforming agent hinted at a simple oncogenic mechanism by which this virus could promote lymphomagenesis. In reality, the pathogenesis of EBV-associated lymphomas involves a complex interplay between different patterns of viral gene expression and cellular genetic changes. Here we review recent developments in our understanding of EBV-associated lymphomagenesis in both the immunocompetent and immunocompromised host. This article is part of the themed issue ‘Human oncogenic viruses’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 924
Self-citationMolecular Diagnosis of Burkitt's Lymphoma
Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E.-J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Self-citationKanzler, H., Küppers, R., Hansmann, M. L., & Rajewsky, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1495 · Cited by 742
Küppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., & Hansmann, M. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10962 · Cited by 672
Molyneux, E. M., Rochford, R., Griffin, B., Newton, R., Jackson, G., Menon, G., Harrison, C. J., Israels, T., & Bailey, S. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61177-x · Cited by 613
Lee, J., Suh, C., Park, Y. H., Ko, Y. H., Bang, S. M., Lee, J. H., Lee, D. H., Huh, J., Oh, S. Y., Kwon, H.-C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1384 · Cited by 608
The genetic landscape of mutations in Burkitt lymphoma
Love, C., Sun, Z., Jima, D., Li, G., Zhang, J., Miles, R., Richards, K. L., Dunphy, C. H., Choi, W. W. L., Srivastava, G., et al. (2012) · Nature Genetics · doi:10.1038/ng.2468 · Cited by 597
Germinal centres and B cell lymphomagenesis
Basso, K., & Dalla-Favera, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3814 · Cited by 510
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
Glaser, S. L., Lin, R. J., Stewart, S. L., Ambinder, R. F., Jarrett, R. F., Brousset, P., Pallesen, G., Gulley, M. L., Khan, G., O'Grady, J., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t · Cited by 506
Post-Transplant Lymphoproliferative Disorders
Gottschalk, S., Rooney, C. M., & Heslop, H. E. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104727 · Cited by 489
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Schmitz, R., Hansmann, M.-L., Bohle, V., Martin-Subero, J. I., Hartmann, S., Mechtersheimer, G., Klapper, W., Vater, I., Giefing, M., Gesk, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090528 · Cited by 481
AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations
Robbiani, D. F., Bothmer, A., Callen, E., Reina-San-Martin, B., Dorsett, Y., Difilippantonio, S., Bolland, D. J., Chen, H. T., Corcoran, A. E., Nussenzweig, A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.062 · Cited by 467
the ICGC MMML-Seq Project (2012) · Nature Genetics · doi:10.1038/ng.2469 · Cited by 440
Pathogenesis of Human B Cell Lymphomas
Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075027 · Cited by 437
Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients
Oyama, T., Ichimura, K., Suzuki, R., Suzumiya, J., Ohshima, K., Yatabe, Y., Yokoi, T., Kojima, M., Kamiya, Y., Taji, H., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200301000-00003 · Cited by 394
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7025 · Cited by 393
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052204 · Cited by 370
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Jiang, L., Gu, Z.-H., Yan, Z.-X., Zhao, X., Xie, Y.-Y., Zhang, Z.-G., Pan, C.-M., Hu, Y., Cai, C.-P., Dong, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3358 · Cited by 366
Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3070 · Cited by 344
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
Reichel, J., Chadburn, A., Rubinstein, P. G., Giulino-Roth, L., Tam, W., Liu, Y., Gaiolla, R., Eng, K., Brody, J., Inghirami, G., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610436 · Cited by 337
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M. E., Xu, Y., Foley, M. H., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · PubMed · Cited by 312
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
Sander, S., Calado, D. P., Srinivasan, L., Köchert, K., Zhang, B., Rosolowski, M., Rodig, S. J., Holzmann, K., Stilgenbauer, S., Siebert, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.012 · Cited by 300
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
Thorley-Lawson, D. A., & Allday, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro2015 · Cited by 282
Mandelbaum, J., Bhagat, G., Tang, H., Mo, T., Brahmachary, M., Shen, Q., Chadburn, A., Rajewsky, K., Tarakhovsky, A., Pasqualucci, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.030 · Cited by 282
Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Koo, G. C., Tan, S. Y., Tang, T., Poon, S. L., Allen, G. E., Tan, L., Chong, S. C., Ong, W. S., Tay, K., Tao, M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0028 · Cited by 275
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.
Joos, S., Küpper, M., Ohl, S., von Bonin, F., Mechtersheimer, G., Bentz, M., Marynen, P., Mӧller, P., Pfreundschuh, M. G., Trümper, L. H. P., et al. (2000) · PubMed · Cited by 273
EBV-positive diffuse large B-cell lymphoma of the elderly
Ok, C. Y., Papathomas, T. G., Medeiros, L. J., & Young, K. H. (2013) · Blood · doi:10.1182/blood-2013-03-489708 · Cited by 260
The pathogenesis of Epstein–Barr virus persistent infection
Thorley-Lawson, D. A., Hawkins, J. B., Tracy, S. I., & Shapiro, M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.04.005 · Cited by 254
Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling
Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., & Chang, Y.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2194 · Cited by 245
Oncogenic Mechanisms in Burkitt Lymphoma
Schmitz, R., Ceribelli, M., Pittaluga, S., Wright, G., & Staudt, L. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014282 · Cited by 245
Post-transplant lymphoproliferative disorders
Dharnidharka, V. R., Webster, A. C., Martinez, O. M., Preiksaitis, J. K., Leblond, V., & Choquet, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.88 · Cited by 235
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
Tam, W., Gomez, M., Chadburn, A., Lee, J. W., Chan, W. C., & Knowles, D. M. (2006) · Blood · doi:10.1182/blood-2005-09-3778 · Cited by 230
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.28.11.1 · Cited by 229
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
Bräuninger, A., Schmitz, R., Bechtel, D., Renné, C., Hansmann, M., & Küppers, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21716 · Cited by 202
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Magrath, I. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09013.x · Cited by 195
Gibson, T. M., Morton, L. M., Shiels, M. S., Clarke, C. A., & Engels, E. A. (2014) · AIDS · doi:10.1097/qad.0000000000000428 · Cited by 190
Roemer, M. G. M., Advani, R. H., Redd, R. A., Pinkus, G. S., Natkunam, Y., Ligon, A. H., Connelly, C. F., Pak, C. J., Carey, C. D., Daadi, S. E., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0201 · Cited by 189
Co-infections, inflammation and oncogenesis: Future directions for EBV research
Rickinson, A. B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.004 · Cited by 184
Self-citationPlasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma
Robbiani, D. F., Deroubaix, S., Feldhahn, N., Oliveira, T. Y., Callen, E., Wang, Q., Jankovic, M., Silva, I. T., Rommel, P. C., Bosque, D., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.019 · Cited by 180
Human immunity against EBV—lessons from the clinic
Tangye, S. G., Palendira, U., & Edwards, E. S. J. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161846 · Cited by 174
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
Abate, F., Ambrosio, M. R., Mundo, L., Laginestra, M. A., Fuligni, F., Rossi, M., Zairis, S., Gazaneo, S., De Falco, G., Lazzi, S., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005158 · Cited by 171
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C., Gribben, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58092 · Cited by 166
Polack, A., Hörtnagel, K., Pajic, A., Christoph, B., Baier, B., Falk, M., Mautner, J., Geltinger, C., Bornkamm, G. W., & Kempkes, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10411 · Cited by 157
Primary Immunodeficiencies Associated with EBV Disease
Cohen, J. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_10 · Cited by 151
Hertel, C., Zhou, X.-G., Hamilton-Dutoit, S., & Junker, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205629 · Cited by 148
Hodgkin lymphoma: Pathology and biology
Mathas, S., Hartmann, S., & Küppers, R. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.05.007 · Cited by 148
A lymphomagenic role for HIV beyond immune suppression?
Dolcetti, R., Gloghini, A., Caruso, A., & Carbone, A. (2016) · Blood · doi:10.1182/blood-2015-11-681411 · Cited by 138
Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Frappier, L. (2012) · Viruses · doi:10.3390/v4091537 · Cited by 137
Loong, F., Chan, A. C. L., Ho, B. C. S., Chau, Y.-P., Lee, H. Y., Cheuk, W., Yuen, W. K., Ng, W.-S., Cheung, H.-L., & Chan, J. K. C. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.168 · Cited by 131
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis
Schulz, T. F., & Cesarman, E. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.08.016 · Cited by 130
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes
Piccaluga, P. P., Falco, G. D., Kustagi, M., Gazzola, A., Agostinelli, C., Tripodo, C., Leucci, E., Onnis, A., Astolfi, A., Sapienza, M. R., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301556 · Cited by 128
Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance
Hislop, A. D., Kuo, M., Drake-Lee, A. B., Akbar, A. N., Bergler, W., Hammerschmitt, N., Khan, N., Palendira, U., Leese, A. M., Timms, J. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24810 · Cited by 128
Self-citationVockerodt, M., Morgan, S., Kuo, M., Wei, W., Chukwuma, M., Arrand, J. R., Kube, D., Gordon, J., Young, L. S., Woodman, C. B. J., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2384 · Cited by 127
Fan, W., Bubman, D., Chadburn, A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.1244-1251.2005 · Cited by 124
Kaymaz, Y., Oduor, C. I., Yu, H., Otieno, J. A., Ong'echa, J. M., Moormann, A. M., & Bailey, J. A. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0305 · Cited by 120
Morscio, J., Dierickx, D., Ferreiro, J. L., Herreman, A., Loo, P. V., Bittoun, E., Verhoef, G. E. G., Matthys, P., Cools, J., Włodarska, I., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12196 · Cited by 120
Aldinucci, D., Celegato, M., & Casagrande, N. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.007 · Cited by 118
Role of genetic and epigenetic changes in Burkitt lymphoma
Lindström, M. S., & Wiman, K. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00058-5 · Cited by 116
A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Torgbor, C., Awuah, P. C., Deitsch, K., Kalantari, P., Duca, K., & Thorley‐Lawson, D. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004170 · Cited by 111
Lu, J. L., Murakami, M., Verma, S. C., Cai, Q., Haldar, S., Kaul, R., Wasik, M. A., Middeldorp, J. M., & Robertson, E. S. (2010) · Virology · doi:10.1016/j.virol.2010.10.029 · Cited by 111
Allday, M. J. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.007 · Cited by 111
Giulino-Roth, L. G., Wang, K., MacDonald, T. Y., Mathew, S., Tam, Y., Cronin, M. T., Palmer, G. A., Lucena‐Silva, N., Pedrosa, F. D. P. R., Pedrosa, M., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437624 · Cited by 108
Chuang, H., Lay, J., Hsieh, W., Wang, H., Chang, Y., Chuang, S., & Su, I. (2005) · Blood · doi:10.1182/blood-2005-04-1406 · Cited by 105
Wood, C. D., Veenstra, H., Khasnis, S., Gunnell, A., Webb, H., Shannon-Lowe, C. D., Andrews, S., Osborne, C. S., & West, M. J. (2016) · eLife · doi:10.7554/elife.18270 · Cited by 104
Self-citationGenetics of Epstein–Barr virus microRNAs
Klinke, O. K., Feederle, R., & Delecluse, H. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.002 · Cited by 103
Vrzalikova, K., Vockerodt, M., Leonard, S. M., Bell, A. I., Wei, W., Schrader, A., Wright, K. L., Kube, D., Rowe, M., Woodman, C. B. J., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307710 · Cited by 97
Self-citationWoon, H. G., Braun, A., Li, J., Smith, C., Edwards, J., Sierro, F., Feng, C. G., Khanna, R., Elliot, M., Bell, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005799 · Cited by 97
Self-citationFerreiro, J. L., Morscio, J., Dierickx, D., Vandenberghe, P., Gheysens, O. S., Verhoef, G. E. G., Esteki, M. Z., Tousseyn, T., & Włodarska, I. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13558 · Cited by 96
Leonard, S. M., Wei, W., Anderton, J. A., Vockerodt, M., Rowe, M., Murray, P. G., & Woodman, C. B. J. (2011) · Journal of Virology · doi:10.1128/jvi.00468-11 · Cited by 95
EPELDEGUI, M., HUNG, Y., MCQUAY, A., AMBINDER, R., & MARTINEZMAZA, O. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.018 · Cited by 93
The tumor virus landscape of AIDS-related lymphomas
Arvey, A. J., Ojesina, A. I., Pedamallu, C. S., Ballon, G., Jung, J., Duke, F. F., Leoncini, L., Falco, G. D., Bressman, E., Tam, W., et al. (2015) · Blood · doi:10.1182/blood-2014-11-599951 · Cited by 92
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
Cozen, W., Timofeeva, M. N., Li, D., Diepstra, A., Hazelett, D. J., Delahaye-Sourdeix, M., Edlund, C. K., Franke, L., Rostgaard, K., Berg, D. J. V. D., et al. (2014) · Nature Communications · doi:10.1038/ncomms4856 · Cited by 89
Epstein-Barr virus and Burkitt lymphoma
Rowe, M., Fitzsimmons, L., & Bell, A. I. (2014) · 癌症:英文版 · doi:10.5732/cjc.014.10190 · Cited by 87
Self-citationNF-κB deregulation in Hodgkin lymphoma
Weniger, M. A., & Küppers, R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.05.001 · Cited by 86
Ambrosio, M. R., Navari, M., Lisio, L. D., Andrés‐León, E., Onnis, A., Gazaneo, S., Mundo, L., Ulivieri, C., Goméz-López, G., Lazzi, S., et al. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-12 · Cited by 84
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
Menter, T., Juškevičius, D., Alikian, M., Steiger, J., Dirnhofer, S., Tzankov, A., & Naresh, K. N. (2017) · British Journal of Haematology · doi:10.1111/bjh.14633 · Cited by 82
Tierney, R. J., Shannon-Lowe, C. D., Fitzsimmons, L., et al. (2014) · Virology · doi:10.1016/j.virol.2014.10.030 · Cited by 79
Self-citationKalchschmidt, J., Bashford-Rogers, R. J. M., Paschos, K., Gillman, A. C. T., Styles, C. T., Kellam, P., & Allday, M. J. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160120 · Cited by 79
Tempera, I., Leo, A. D., Kossenkov, A. V., Cesaroni, M., Song, H., Dawany, N. B., Showe, L. C., Lu, F. Y., Wickramasinghe, P., & Lieberman, P. M. (2015) · Journal of Virology · doi:10.1128/jvi.02318-15 · Cited by 78
The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
Liu, Y., Razak, F. R. A., Terpstra, M. M., Chan, F. C., Saber, A., Nijland, M., Imhoff, G. W. V., Visser, L., Gascoyne, R. D., Steidl, C., et al. (2014) · Leukemia · doi:10.1038/leu.2014.201 · Cited by 77
Kato, H., Karube, K., Yamamoto, K., et al. (2014) · Cancer Science · doi:10.1111/cas.12389 · Cited by 76
Molecular underpinning of extranodal NK/T-cell lymphoma
Huang, Y., de Leval, L., & Gaulard, P. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.04.006 · Cited by 72
Fox, C. P., Shannon‐Lowe, C., Gothard, P., Kishore, B., Neilson, J. R., O’Connor, N., & Rowe, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653424 · Cited by 61
Self-citationCohen, M., Narbaitz, M., Metrebian, F., Matteo, E. D., Preciado, M. V., & Chabay, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.28942 · Cited by 58
Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cells
Pajic, A., Staege, M. S., Dudziak, D., Schuhmacher, M., Spitkovsky, D. D., Eissner, G., Brielmeier, M., Polack, A., & Bornkamm, G. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.1404 · Cited by 58
Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia
Boultwood, J., Fidler, C., Shepherd, P. C. A., Watkins, F., Snowball, J., Haynes, S., Kušec, R., Gaiger, A., Littlewood, T. J., Peniket, A. J., et al. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199905)61:1<26::aid-ajh6>3.0.co;2-r · Cited by 53
The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders
Glotz, D., Chapman, J. R., Dharnidharka, V. R., Hanto, D. W., de Castro, M. C. R., Hirsch, H. H., Leblond, V., Mehta, A. K., Moulin, B., Pagliuca, A., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318269e64f · Cited by 50
Self-citationEpstein–Barr virus‐induced epigenetic alterations following transient infection
Queen, K. J., Shi, M., Zhang, F., Cvek, U., & Scott, R. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27893 · Cited by 49
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
Piccaluga, P. P., Navari, M., Falco, G. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4399 · Cited by 48
Epstein-Barr viral microRNAs target caspase 3
Harold, C. M., Cox, D., & Riley, K. J.-L. (2016) · Virology Journal · doi:10.1186/s12985-016-0602-7 · Cited by 46
Interleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma.
Kanno, H., Yasunaga, Y., Iuchi, K., Yamauchi, S., Tatekawa, T., Sugiyama, H., & Aozasa, K. (1996) · PubMed · Cited by 38
Oyoshi, M. K., Nagata, H., Kimura, N., Zhang, Y., Demachi, A., Hara, T., Kanegane, H., Matsuo, Y., Yamaguchi, T., Morio, T., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64297-6 · Cited by 31
c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma
Scheller, H. V., Tobollik, S., Kutzera, A., Eder, M. D., Unterlehberg, J., Pfeil, I., & Jungnickel, B. (2009) · Oncogene · doi:10.1038/onc.2009.377 · Cited by 31
Sierra, D. M. C., Vélez-Colmenares, E. G., Orfao, A., Herrera, M. V., Solano, J. C., Olaya, M., Uribe, A. M., Saavedra, C., Duarte, M., Rodríguez, M., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12682 · Cited by 28
Sebastián, E., Alcoceba, M., Martin‐García, D., Blanco, Ó., Sánchez‐Barba, M., Balanzategui, A., Marín, L., Montes‐Moreno, S., González-Barca, E. M., Pardal, E., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2552-3 · Cited by 23
Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis
Guan, H., Xie, L., Wirth, T., & Ushmorov, A. (2016) · Oncotarget · doi:10.18632/oncotarget.9210 · Cited by 13
Cited by
The Global Landscape of EBV-Associated Tumors
Shannon-Lowe, C., & Rickinson, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00713 · Cited by 459
Self-citationAllen, U. D., Preiksaitis, J. K., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13652 · Cited by 375
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Mrozek-Gorska, P., Buschle, A., Pich, D., Schwarzmayr, T., Fechtner, R., Scialdone, A., & Hammerschmidt, W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901314116 · Cited by 210
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation
Wang, L. W., Shen, H., Nobre, L., Ersing, I., Paulo, J. A., Trudeau, S., Wang, Z., Smith, N. A., Ma, Y., Reinstadler, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.003 · Cited by 190
Metadata
- Authors
- Shannon-Lowe, C., Rickinson, A. B., & Bell, A. I.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2017-09-11
- Volume
- 372
- Issue
- 1732
- Pages
- 20160271
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2755325205
- Cited by
- 428
- References
- 104
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.